RecruitingNCT06556251
A digital support platform for people in early psychosis care
About this title
Read the official source — NCT06556251Device studyAges 18–40SpainSchizophrenia
Understand this study
Who could participate?
Listed age limits: 18 years to 40 years.
- Listed locations
- Sant Boi de LlobregatSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: September 18, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 128
- Sponsor
- Fundació Sant Joan de Déu
- Sponsor type
- Unknown or unclear
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- Spain
- Age range
- From 18 Years to 40 Years
- Official registry ID
- NCT06556251
- Official title
Show the full official title
Evaluating the Effectiveness of a Digital Platform in the Engagement and Prognosis of Patients in the Early Intervention Programme in Psychosis
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Sant Boi de Llobregat
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Fundació Sant Joan de Déu.
Who can participate?
Listed age limits: 18 years to 40 years.
Is this study still recruiting?
The registry lists this study as recruiting.
Want to explore more studies?
Explore studiesRelated studies
Clozapine versus usual second-line treatment after a first schizophrenia treatment fails
A double blind, randomized, placebo-controlled, adaptive 24-week Phase IIb trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia....